换一批Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging.
第一作者：
Anna,Degrassi
第一单位：
Pharmacology Department, BU Oncology, Nerviano Medical Sciences, Milano, Italy. Anna.Degrassi@nervianoms.com
作者：
主题词
腺癌(Adenocarcinoma);氨基酸取代(Amino Acid Substitution);动物(Animals);抗肿瘤药(Antineoplastic Agents);天冬氨酸(Aspartic Acid);细胞周期蛋白质依赖激酶类(Cyclin-Dependent Kinases);诊断显像(Diagnostic Imaging);疾病模型, 动物(Disease Models, Animal);药物评价, 临床前(Drug Evaluation, Preclinical);基因, ras(Genes, ras);甘氨酸(Glycine);人类(Humans);肺肿瘤(Lung Neoplasms);小鼠(Mice);小鼠, 转基因(Mice, Transgenic);突变蛋白质类(Mutant Proteins);吡唑类(Pyrazoles);喹唑啉类(Quinazolines);治疗结果(Treatment Outcome)
DOI
10.1158/1535-7163.MCT-09-0726
PMID
20197397
发布时间
2020-09-30
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
